Medpace Holdings (MEDP) Tops Q2 EPS by 12c, provides guidance

Medpace Holdings (NASDAQ: MEDP) reported Q2 EPS of $3.10, $0.12 better than the analyst estimate of $2.98. Revenue for the quarter came in at $603.3 million versus the consensus estimate of $538.81 million.

GUIDANCE:

Medpace Holdings sees FY2025 revenue of $2.42-2.52 billion, versus the consensus of $2.185 billion.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August